Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982660priorityCriticalpatent/ECSP982660A/en
Publication of ECSP982660ApublicationCriticalpatent/ECSP982660A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención proporciona métodos de cicatrización de hueso y reparación de fracturas que comprenden la administración a un paciente que lo necesita de una cantidad eficaz de un análogo popipeptidico del péptido relacionado con la hormona paratiroidea (PTHrKP) y de sales del mismo, en el cual los residuos aminoacidicos 22-31 forman una élice alfa anfipática, o el uso de dicho polipéptido para la preparación de un medicamento para el tratamiento de cicatrización de hueso y reparación de fracturas.The present invention provides methods of bone healing and fracture repair comprising administration to a patient in need of an effective amount of a parathyroid hormone-related peptide (PTHrKP) popypeptide analog, in which amino acid residues 22-31 form an amphipathic alpha elice, or the use of said polypeptide for the preparation of a medicament for the treatment of bone healing and fracture repair.
ECSP9826601998-09-081998-09-08
USE OF PTHrP ANALOGS IN FRACTURE HEALING
ECSP982660A
(en)
USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
ABETA FRAGMENT JOINED WITH A BEARING PEPTIDE TO PREVENT OR TREAT DISEASES ASSOCIATED WITH ABETA AMILOID DEPOSITS, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND ITS USE IN THE PREPARATION OF MEDICINES.
MEDICINAL PRODUCT FOR TREATMENT OF INFARTED MYOCARDIAL TISSUE THAT INCLUDES DARK MIOBLASTS OF GENETICALLY MODIFIED MAMMALS TO EXPRESS THE MAMIFERO PROTEIN SDF-1
USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
USE OF AN EFFECTIVE AMOUNT OF AT LEAST ONE PEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICATION INTENDED TO PARATRATE INFLAMMATION, AND A COSMETIC TREATMENT PROCEDURE THROUGH A COSMETIC COMPOSITION CONTAINING SUCH PEPTIDE.
AN IMPROVED PEPTIDE, IMMUNOGENIC COMPOSITION AND VACCINE OR MEDICAL PREPARATION, A PROCEDURE TO IMMUNIZE ANIMALS AGAINST LHRH HORMONE, ANALOGS OF LHRH PEPTIDE REPEATED IN TANDEM AND ITS USE AS A VACCINE.